Gallic acid against hepatocellular carcinoma: An integrated scheme of the potential mechanisms of action from study
The global burden of hepatocellular carcinoma is increasing; actually, it is estimated as 750,000 new cases annually. This study was initiated to emphasize the possibility that gallic acid could alleviate hepatocarcinogenesis in vivo . In this study, 40 rats were enrolled and distributed as follows;...
Saved in:
| Main Authors: | Hadeer A Aglan, Hanaa H Ahmed, Sayed A El-Toumy, Nadia S Mahmoud |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2017-05-01
|
| Series: | Tumor Biology |
| Online Access: | https://doi.org/10.1177/1010428317699127 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Role of CD133 antibody-conjugated nanocarrier in enhancing the targetability of hepatocellular carcinoma stem cells
by: Hadeer A. Aglan, et al.
Published: (2025-08-01) -
Gallic Acid Bacteriostatic Activity and Mechanism Against Vibrio alginolyticus
by: Chunyuan WANG, et al.
Published: (2025-06-01) -
The promising role of hypoxia-resistant insulin-producing cells in ameliorating diabetes mellitus in vivo
by: Hanaa H Ahmed, et al.
Published: (2022-08-01) -
Gallic acid showed neuroprotection against endoplasmic reticulum stress in rats
by: Abdulmutalip Karaaslanlı, et al.
Published: (2025-01-01) -
Methyl gallate, gallic acid-derived compound, inhibit cell proliferation through increasing ROS production and apoptosis in hepatocellular carcinoma cells.
by: Chien-Yu Huang, et al.
Published: (2021-01-01)